Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-16-000005
Filing Date
2016-11-03
Accepted
2016-11-02 17:45:27
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptct0930201610-q.htm 10-Q 1415479
2 EXHIBIT 31.1 ptct09302016ex-311.htm EX-31.1 14369
3 EXHIBIT 31.2 ptct09302016ex-312.htm EX-31.2 14357
4 EXHIBIT 32.1 ptct09302016ex-321.htm EX-32.1 7327
5 EXHIBIT 32.2 ptct09302016ex-322.htm EX-32.2 7300
  Complete submission text file 0001070081-16-000005.txt   5735698

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptct-20160930.xml EX-101.INS 1099596
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20160930.xsd EX-101.SCH 35280
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20160930_cal.xml EX-101.CAL 59479
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20160930_def.xml EX-101.DEF 213202
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20160930_lab.xml EX-101.LAB 563167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20160930_pre.xml EX-101.PRE 324865
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 161969237
SIC: 2834 Pharmaceutical Preparations